CDSCO declares 58 drug samples it tested in the month of February as Not of Standard Quality. high bp

CDSCO declares 58 drug samples it tested in the month of February as Not of Standard Quality.  high bp


The Central Drugs Standard Control Organization (CDSCO) had sent 1,167 medicines for quality testing in the month of February. From which it has been revealed that 58 medicines lack standard quality. At the same time, two medicines have been declared fake medicines. On which further investigation is still going on.

According to the report, 1,167 drug samples were specially tested in the lab, out of which 1,018 samples were declared of standard quality. About five per cent of the total samples tested have been declared NSQ, which was almost the same level in the previous month of January, 2024, according to CDSCO data.

CDSCO issues red alert regarding these medicines

In January this year, 40 medicines and injections manufactured in 25 pharmaceutical factories of Himachal were declared sub-standard. They include medicines and injections used in asthma, fever, diabetes, high blood pressure, allergy, epilepsy, cough, antibiotic, bronchial and gastric.

This medicine for high BP is fake

CDSCO said a batch of high BP control drugs Telma AM (telmisartan 40 mg and amlodipine 5 mg tablets) and Telma 40 (telmisartan 40 mg), said to be manufactured by Glenmark Pharmaceuticals, failed quality tests. And the company informed that the batch of products was not manufactured by them and it is a counterfeit medicine.

Samples of these medicines failed in quality check

These drug samples which were declared as NSQ include Acepic-P (aceclofenac and paracetamol tablets) manufactured by Nexchem Biotech Pvt Ltd in Himachal Pradesh, Calcigiant 500 tablets (calcium carbonate and vitamin D) manufactured by Nutra Life Healthcare in Uttarakhand. 3), Contains OFlab.

100 DT (Ofloxacin dispersible tablets 100 mg) manufactured by Concept Pharmaceuticals, Aurangabad, Mahakali 500 (Calcium and Vitamin D3 tablets) manufactured by Hanuchem Laboratories, Himachal Pradesh, Cerizyme tablets (Serratiopeptidase) manufactured by Arnav Research Laboratories, Gujarat, XL-Mont ( Montelukast) sodium and Levocetirizine hydrochloride tablets by DWD Pharmaceuticals, Gujarat), Hyprovan 500 Injection (Propofol Injection IP 500 mg/50 ml) by Protec Telelinks, Himachal Pradesh, Heparin Sodium Injection 25,000 IU/5 ml by Sai Parenterals Ltd, Telangana.

CDSCO also said that ‘Sun Pharma Laboratories’ has informed that the samples of anticonvulsant drug Levipill 500 (Levetiracetam tablets) reported to be manufactured by the company, and failed the quality test in the month of January, were not manufactured by the company. And that it is a fake medicine. CDSCO said that the product is being declared counterfeit, however, this is dependent on the outcome of further investigation.

The organization has tested 932 samples in January, of which about five percent or 46 samples were declared NSQ. No sample was declared counterfeit or misbranded during the month

During the month of February, more than one sample of some companies like Orchid Bio-Tech, Uttarakhand, MC Pharmaceuticals, Himachal Pradesh and Ridley Life Science Private Limited, Delhi was declared NSQ.

Check out below Health Tools-
Calculate Your Body Mass Index (BMI)

Calculate The Age Through Age Calculator



Source link

Related posts

Leave a Reply